Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Advanced or locally advanced breast cancer Age: Adult Condition: In women who are no longer responsive to anti-oestrogen therapy |
Dose: Oral – 25 mg Frequency: once daily |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: Not applicable – No approved pediatric dosage available Note: No approved pediatric dosage available |
Administration
- Take after meal
- Take at same time daily
Side Effect
- Fatigue (22%)
- Nausea (18%)
- Hot flashes (13%)
- Depression (13%)
- Pain (13%)
- Insomnia (11%)
- Anxiety (10%)
- Dyspnea (10%)
- Dizziness (8%)
- Headache (8%)
- Edema (7%)
- Vomiting (7%)
- Flu-like syndrome (6%)
- Abdominal pain (6%)
- Anorexia (6%)
- Cough (6%)
- Hypertension (5%)
- Constipation (5%)
- Diarrhea (4%)
- Cardiac failure
- Uterine polyps
- Endometrial hyperplasia
- Gastric ulcer
- Hepatitis
- Visual disturbances
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP3A4 enzyme inducers
|
May result in reduced plasma levels of exemestane
|
|
Oestrogen-containing drugs, St. John's wort, black cohosh, dong quai
|
Interactions noted, but effects not specified
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.